Ipaflex

Naproxen Sodium, the active ingredient in Ipaflex, is a nonsteroidal anti‑inflammatory drug presented as an oral dosage form for oral use. It treats mild to moderate pain, inflammatory joint conditions such as osteoarthritis and rheumatoid arthritis, and reduces fever. GNH USA supplies Ipaflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipaflex, a nonsteroidal anti‑inflammatory drug, is employed in several common painful and inflammatory conditions. - Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches and postoperative discomfort. - Osteoarthritis: reduces joint inflammation and improves mobility in degenerative joint disease. - Rheumatoid arthritis: alleviates inflammatory symptoms and joint swelling in autoimmune arthritis. - Fever: lowers elevated body temperature associated with infection or inflammation.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Elevated blood pressure. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe allergic reactions: angioedema, anaphylaxis. - Hepatotoxicity: elevated liver enzymes. - Renal impairment: reduced kidney function. - Cardiovascular events: increased risk of thrombotic events. - Hematologic abnormalities: thrombocytopenia or anemia.

Before using Ipaflex, consider the following safety measures: - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate cardiovascular status: use cautiously in patients with heart disease or hypertension. - Monitor renal function: adjust use in patients with impaired kidney function. - Review concomitant medications: avoid combining with other NSAIDs or anticoagulants without medical advice. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: may reduce renal perfusion. - Lithium: naproxen can increase lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - Corticosteroids: additive risk of GI ulceration. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect.